Clincosm LogoSign in Get a demo

Pancreatic Cancer

Showing 51 - 75 of 1,502
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer Trial in Hangzhou (Canagliflozin and Gemcitabine, Gemcitabine)

Not yet recruiting
  • Pancreatic Cancer
  • Hangzhou, Zhejiang, China
    Hangzhou first people's Hospital
Jun 11, 2023

Non Small Cell Lung Cancer, Solid Tumors, Adult, Endometrial Cancer Trial in Fairfax (TNG260, Pembrolizumab)

Recruiting
  • Non Small Cell Lung Cancer
  • +6 more
  • Fairfax, Virginia
    NEXT Oncology
Jun 7, 2023

Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer Trial in Anqing (Recombinant oncolytic herpes simplex virus type 1

Recruiting
  • Lung Cancer
  • +11 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Anqing, Anhui, China
    The PLA Navy Anqing Hospital
May 23, 2023

Pancreatic Cancer Trial in Beijing (68Ga-FAPI-FS PET/CT)

Recruiting
  • Pancreatic Cancer
  • 68Ga-FAPI-FS PET/CT
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 16, 2023

Solid Tumor, Adult, Advanced Solid Tumor, Head Neck Cancer Trial in Irving, San Antonio, West Valley City (SNS-101 (anti-VISTA),

Recruiting
  • Solid Tumor, Adult
  • +19 more
  • Irving, Texas
  • +2 more
May 24, 2023

Advanced Solid Tumor, Metastatic Solid Tumor, Lung Cancer Trial in Seoul, Incheon (WM-A1-3389, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumor
  • +7 more
  • WM-A1-3389
  • Pembrolizumab
  • Seoul, Seocho-gu, Korea, Republic of
  • +1 more
May 14, 2023

Sarcoma, Carcinoma, Breast Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type 1 (R130))

Recruiting
  • Sarcoma
  • +8 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Shanghai, Jiangsu, China
    Xuzhou Second People's Hospital
May 8, 2023

Pancreatic Cancer Trial in China (AK104, Gemcitabine, Nab-Paclitaxel)

Not yet recruiting
  • Pancreatic Cancer
  • Beijing, Beijing, China
  • +6 more
May 5, 2023

Pancreatic Cancer Trial in Meldola, Ravenna (Losartan, Gemcitabine, Nab paclitaxel)

Not yet recruiting
  • Pancreatic Cancer
  • Meldola, Forlì, Italy
  • +1 more
May 12, 2023

Breast Cancer Metastatic, Pancreatic Cancer, NSCLC, Metastatic Trial in Denver, Grand Rapids (ST316)

Not yet recruiting
  • Breast Cancer Metastatic
  • +7 more
  • Denver, Colorado
  • +1 more
Apr 28, 2023

Pancreatic Cancer, Gastric Cancer Trial in Hangzhou (Biopsy of tumor tissue for organoid culture)

Recruiting
  • Pancreatic Cancer
  • Gastric Cancer
  • Biopsy of tumor tissue for organoid culture
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University School of med
Apr 22, 2023

Invasive Ductal Breast Carcinoma, Invasive Ductal Breast Carcinoma Stage IV, Lobular Breast Carcinoma Trial in United States

Recruiting
  • Invasive Ductal Breast Carcinoma
  • +14 more
  • Stereotactic body radiotherapy
  • Lattice Radiation Therapy
  • Basking Ridge, New Jersey
  • +6 more
Apr 20, 2023

oncRNA Stratification of Cancer by Size and Stage

Not yet recruiting
  • Kidney Cancer
  • +32 more
  • Exai oncRNA blood test
  • (no location specified)
Apr 27, 2023

Pancreatic Cancer Trial in Houston (Enhanced Usual Care, Tele-supervised resistance exercises)

Not yet recruiting
  • Pancreatic Cancer
  • Enhanced Usual Care
  • Tele-supervised resistance exercises
  • Houston, Texas
    M D Anderson Cancer Center
Apr 20, 2023

Seismofit® asEstimate of VO2 Peak in Hepato-pancreato-biliary,

Recruiting
  • Hepato-Biliary Carcinoma in Situ Nos
  • +4 more
  • Non-Interventional
  • London, United Kingdom
    The Royal Marsden NHS Foundation Trust
Apr 24, 2023

Pancreatic Cancer Trial in Shanghai (IN10018, Albumin-Bound Paclitaxel, Gemcitabine)

Recruiting
  • Pancreatic Cancer
  • Shanghai, Shanghai, China
    Renji Hospital of Shanghai Jiaotong University School of Medicin
Apr 23, 2023

Pancreatic Cancer, Resectable Carcinoma Trial in Beijing (Later-line therapy)

Recruiting
  • Pancreatic Cancer
  • Resectable Carcinoma
  • Later-line therapy
  • Beijing, China
    Department of Medical Oncology, Peking Union Medical College Hos
Apr 10, 2023

Pancreatic Cancer, Locally Advanced Trial in Beijing (Later-line therapy)

Recruiting
  • Pancreatic Cancer
  • Locally Advanced
  • Later-line therapy
  • Beijing, China
    Department of Medical Oncology, Peking Union Medical College Hos
Apr 10, 2023

Pancreatic Cancer, Advanced Cancer, Metastatic Cancer Trial in Beijing (Later-line therapy)

Recruiting
  • Pancreatic Cancer
  • +2 more
  • Later-line therapy
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Apr 10, 2023

Pancreatic Cancer, Surgery, Metastasis Trial (Histamine DiHCl (HDC), Interleukin-2 (IL-2))

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Histamine Dihydrochloride (HDC)
  • Interleukin-2 (IL-2)
  • (no location specified)
Mar 31, 2023

NSCLC, Gastric Cancer, Head Neck Cancer Trial (CDX-585)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +13 more
  • (no location specified)
Mar 29, 2023

Pancreatic Cancer Trial in Shanghai (Stereotactic body radiation therapy plus vNKT cell adoptive therapy)

Recruiting
  • Pancreatic Cancer
  • Stereotactic body radiation therapy plus vNKT cell adoptive therapy
  • Shanghai, China
    Changhai Hospital affiliated to Naval Medical University
Mar 13, 2023

Pancreatic Cancer Trial in Netherlands (Cefuroxime, Metronidazole)

Not yet recruiting
  • Pancreatic Cancer
  • Leiden, Zuid Holland, Netherlands
  • +10 more
Mar 22, 2023

Pancreatic Cancer, Metastatic Adenocarcinoma Trial in Winston-Salem (Nab paclitaxel, Gemcitabine, TheraBionic)

Not yet recruiting
  • Pancreatic Cancer
  • Metastatic Adenocarcinoma
  • Nab paclitaxel
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Mar 8, 2023

Pancreatic Cancer Trial in Saint Louis (Daily Adaptive External Beam Radiation Therapy)

Recruiting
  • Pancreatic Cancer
  • Daily Adaptive External Beam Radiation Therapy
  • Saint Louis, Missouri
    Washington University, St. Louis
Mar 7, 2023